Effect and Mechanism of Modified Erchentang on Immune Function, CCL18, CC16, IL-8 and sICAM-1 in Patients at Acute Exacerbation Stage of COPD

CHEN Si-qing; XIE Wen-ying; SHANG Li-zhi; XUE Hong-li; LIU Zhi-yong; DU Hong-yan; ZHAO Xian-min; LIU Xiao-hui; SUN Chun-yang; JI Shu; LU Chang-qing; ZHANG Miao; LIANG Juan-juan; WANG Yi

doi:10.13422/j.cnki.syfjx.2017100171

您当前的位置：

首页 >

文章列表页 >

Effect and Mechanism of Modified Erchentang on Immune Function, CCL18, CC16, IL-8 and sICAM-1 in Patients at Acute Exacerbation Stage of COPD

更新时间：2024-01-04

- Effect and Mechanism of Modified Erchentang on Immune Function, CCL18, CC16, IL-8 and sICAM-1 in Patients at Acute Exacerbation Stage of COPD
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 10, Pages: 171-177(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017100171
  CLC： R563.9
- Published：2017
- 稿件说明：
移动端阅览
CHEN Si-qing, XIE Wen-ying, SHANG Li-zhi, et al. Effect and Mechanism of Modified Erchentang on Immune Function, CCL18, CC16, IL-8 and sICAM-1 in Patients at Acute Exacerbation Stage of COPD[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(10): 171-177.
DOI：

CHEN Si-qing, XIE Wen-ying, SHANG Li-zhi, et al. Effect and Mechanism of Modified Erchentang on Immune Function, CCL18, CC16, IL-8 and sICAM-1 in Patients at Acute Exacerbation Stage of COPD[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(10): 171-177. DOI： 10.13422/j.cnki.syfjx.2017100171.

摘要

目的：观察二陈汤加味对慢性阻塞性肺疾病急性加重期（acute exacerbation period of COPD，AECOPD）患者肺功能、细胞和体液免疫功能，细胞趋化因子18（chemoattractant cytokine18，CCL18），白细胞介素-8（interleukin-8，IL-8），Clara细胞蛋白（Clara cell protein，CC16）和可溶性细胞间黏附分子-1（soluble intercellular adhesion molecular-1，sICAM-1）的影响。方法：选取符合纳入标准的老年AECOPD患者120例，分为治疗组与对照组，每组60例。两组均在常规治疗的基础上，治疗组给予二陈汤加味，每日2次，疗程14 d。14 d后评价两组患者临床疗效，检测肺功能、免疫球蛋白、外周血淋巴细胞亚群，酶联免疫吸附试验（ELISA）测定患者血浆和呼气冷凝液（exhale breath condensat，EBC）中CCL18，CC16，IL-8，sICAM-1浓度。结果：与对照组治疗后比较，治疗组总有效率高于对照组（P<0.05）；治疗组1 s用力呼气容积（FEV1），1 s用力呼气量/用力肺活量（FVC）均增大（P<0.01）；炎细胞总数、中性粒细胞数、单核细胞和淋巴细胞均减少（P<0.05）。与本组治疗前比较，IgG，IgA，IgM无明显差异；CD3+，CD4+，CD4+／CD8+均增加，CD8+降低（P<0.05）；血浆CCL18，CC16，IL-8，sICAM-1均降低（P<0.05），EBC中CCL18，CC16均降低（P<0.05）。结论：二陈汤加味可调节T淋巴细胞亚群功能，增强细胞免疫，降低老年AECOPD患者血浆，EBC中CCL18，CC16，IL-8，sICAM-1水平，对老年AECOPD有一定的抗炎作用。

Abstract

Objective: To observe the effect and mechanism of modified Erchentang on immune function

chemoattractant cytokine 18 (CCL18)

interleukin-8 (IL-8)

clara cell protein (CC16) and soluble intercellular adhesion molecular-1 (sICAM-1) in patients at acute exacerbation stage of COPD (AECOPD). Method: Totally 120 cases of elder AECOPD patients were randomly divided into modified Erchentang group and placebo-controlled group

with 60 cases in each group. In addition to western drugs

modified Erchentang was also used in modified Erchentang group

and placebo was also used in control group for 14 days. Their pulmonary function was detected

and euzyme-linked immunosorbent assay was used to determine the levels of CCL18

CC16

IL-8 and sICAM-1 in patients' plasma and exhaled breath condensate of all groups before and after treatment. Result: Compared with control group

treatment group showed increases in total effective rate (P<0.05)

and FEV1 and FEV1% (P<0.01)

but decreases in total inflammatory cell counts

neutrophil counts

monocytes and lymphocytes (P<0.05). Compared with before treatment

the group showed no significant difference in IgG

IgA

IgM

increases in CD3+

CD4+

CD4+/CD8+ and decreases in CD8+

CCL18

CC16

IL-8

sICAM-1

CCL18 and CC16 in EBC (P<0.05). Conclusion: Modified Erchentang has an anti-inflammatory effect on AECOPD by reducing level of inflammation medium CCL18

CC16

IL-8 and sICAM-1

preventing inflammation progress and adjusting the immune function.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Wuzi Yanzong Pill on Memory,Immune Function, Anti-hypoxia and Anti-fatigue in Mice

Effects of Shenqi Bufei Tang on Bronchus Tissue Conformation and Lung Function of Chronic Opstructive Pulmonary Disease Rat Model with Lung-qi Deficiency Syndrome

Immue-improving Effect of Fuzheng Guben Granule Combined with Radiotherapy and Chemotherapy on Tumor-bearing Mice

Chronic Obstructive Pulmonary Disease in Stable Stage Treated with Jiajian Bufei Decoction

Immue-improving Effect of Fuzheng Guben Granule Combined with Radiotherapy and Chemotherapy on Tumor-bearing Mice

Related Author

LIU Jian-xun

GE Zheng-yan

JIN Long

CHEN Yu-jiang

LIU Yao

ZHANG Kui

ZHANG Pei-qin

ZHANG Ran

Related Institution

Traditional Chinese Medicine Institute of Shanxi Province

Shanxi Zhendong Kaiyuan Pharmaceutical Co.,Ltd.

Hospital of Taiyuan University of Technology

Fist Affiliated Hospital of Guiyang College of Traditional Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰